Human coxsackie adenovirus receptor (CAR) expression in transgenic mouse prostate tumors enhances adenoviral delivery of genes
- 10 March 2005
- journal article
- Published by Wiley in The Prostate
- Vol. 64 (4) , 401-407
- https://doi.org/10.1002/pros.20265
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Myc-driven murine prostate cancer shares molecular features with human prostate tumorsCancer Cell, 2003
- Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectorsGene Therapy, 2001
- A mouse model for adenovirus gene deliveryProceedings of the National Academy of Sciences, 2001
- Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriersGene Therapy, 1999
- Modification of the Genetic Program of Human Alveolar Macrophages by Adenovirus Vectors In Vitro Is Feasible but Inefficient, Limited in Part by the Low Level of Expression of the Coxsackie/Adenovirus ReceptorAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- ‘Green mice’ as a source of ubiquitous green cellsFEBS Letters, 1997
- HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackievirusesProceedings of the National Academy of Sciences, 1997
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993